Literature DB >> 36069779

Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam.

Markus M Heimesaat1, Soraya Mousavi1, Rasmus Bandick1, Stefan Bereswill1.   

Abstract

Gut microbiota depletion is a pivotal prerequisite to warrant Campylobacter jejuni infection and induced inflammation in IL-10-/- mice used as acute campylobacteriosis model. We here assessed the impact of an 8-week antibiotic regimen of ampicillin, ciprofloxacin, imipenem, metronidazole, and vancomycin (ABx) as compared to ampicillin plus sulbactam (A/S) on gut microbiota depletion and immunopathological responses upon oral C. jejuni infection. Our obtained results revealed that both antibiotic regimens were comparably effective in depleting the murine gut microbiota facilitating similar pathogenic colonization alongside the gastrointestinal tract following oral infection. Irrespective of the preceding microbiota depletion regimen, mice were similarly compromised by acute C. jejuni induced enterocolitis as indicated by comparable clinical scores and macroscopic as well as microscopic sequelae such as colonic histopathology and apoptosis on day 6 post-infection. Furthermore, innate and adaptive immune cell responses in the large intestines were similar in both infected cohorts, which also held true for intestinal, extra-intestinal and even systemic secretion of pro-inflammatory cytokines such as TNF-α, IFN-γ, and IL-6. In conclusion, gut microbiota depletion in IL-10-/- mice by ampicillin plus sulbactam is sufficient to investigate both, C. jejuni infection and the immunopathological features of acute campylobacteriosis.

Entities:  

Keywords:  Campylobacter jejuni; acute campylobacteriosis model; ampicillin plus sulbactam; broad-spectrum antibiotic treatment; differential gut microbiota depletion; enteropathogenic infection; host-pathogen interaction; microbiota-depleted IL-10-/- mice

Year:  2022        PMID: 36069779      PMCID: PMC9530677          DOI: 10.1556/1886.2022.00014

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  22 in total

1.  Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data.

Authors:  Thomas P Van Boeckel; Sumanth Gandra; Ashvin Ashok; Quentin Caudron; Bryan T Grenfell; Simon A Levin; Ramanan Laxminarayan
Journal:  Lancet Infect Dis       Date:  2014-07-09       Impact factor: 25.071

2.  Comparative clinical trial of mebendazole and metronidazole in giardiasis of children.

Authors:  S M Sadjjadi; A W Alborzi; H Mostovfi
Journal:  J Trop Pediatr       Date:  2001-06       Impact factor: 1.165

Review 3.  Pathophysiology of Campylobacter enteritis.

Authors:  R I Walker; M B Caldwell; E C Lee; P Guerry; T J Trust; G M Ruiz-Palacios
Journal:  Microbiol Rev       Date:  1986-03

4.  The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis.

Authors:  Markus M Heimesaat; Eliezer Giladi; Anja A Kühl; Stefan Bereswill; Illana Gozes
Journal:  Peptides       Date:  2017-12-27       Impact factor: 3.750

5.  Campylobacter jejuni colonization of mice with limited enteric flora.

Authors:  Christopher Chang; Jeff F Miller
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

Review 6.  The second century of Campylobacter research: recent advances, new opportunities and old problems.

Authors:  Nick Dorrell; Brendan W Wren
Journal:  Curr Opin Infect Dis       Date:  2007-10       Impact factor: 4.915

7.  Resilience to bacterial infection: difference between species could be due to proteins in serum.

Authors:  H Shaw Warren; Catherine Fitting; Eva Hoff; Minou Adib-Conquy; Laura Beasley-Topliffe; Brenda Tesini; Xueya Liang; Catherine Valentine; Judith Hellman; Douglas Hayden; Jean-Marc Cavaillon
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.

Authors:  Markus M Heimesaat; Marie Alutis; Ursula Grundmann; André Fischer; Nicole Tegtmeyer; Manja Böhm; Anja A Kühl; Ulf B Göbel; Steffen Backert; Stefan Bereswill
Journal:  Front Cell Infect Microbiol       Date:  2014-06-10       Impact factor: 5.293

Review 9.  Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models.

Authors:  Ulrike Fiebiger; Stefan Bereswill; Markus M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-12-01

Review 10.  Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Microorganisms       Date:  2020-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.